solithromycin: Clinical Trials

5 trials of solithromycin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated. 5 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Terminated 2
Phase 31Terminated 1

Follow solithromycin: new trials by email Literature Review of solithromycin trials Research Report on solithromycin

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia
Solithromycin, Standard of Care - Community-acquired Bacterial Pneumonia
Phase 2 / Phase 3TerminatedMelinta Therapeutics, Inc.972016-04-012019-01-03
Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis
solithromycin - Nonalcoholic Steatohepatitis
Phase 2CompletedMelinta Therapeutics, Inc.102015-12-012017-03-21
A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary Disease
Solithromycin, Placebo - Pulmonary Disease, Chronic Obstructive
Phase 2TerminatedImperial College London62015-07-012019-12-30
Safety and Efficacy Study of Single-Dose Oral CEM-101 in Patients With Uncomplicated Urogenital Gonorrhea
solithromycin, Solithromycin (CEM-101) - Uncomplicated Urogenital Gonorrhea
Phase 2CompletedMelinta Therapeutics, Inc.602012-05-012017-03-03
Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Levofloxacin, CEM-101 - Community-Acquired Bacterial Pneumonia
Phase 2CompletedMelinta Therapeutics, Inc.1322010-08-012017-03-03

Conditions studied

Inflammation (1)  ·  Liver Diseases (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Pneumonia (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Sponsors

Melinta Therapeutics, Inc. (4)  ·  Imperial College London (1)

Countries

United States (4)  ·  United Kingdom (2)  ·  Bulgaria (1)  ·  Canada (1)  ·  Hungary (1)  ·  Philippines (1)  ·  Spain (1)

Top investigators

Edward W Hook, MD (1)  ·  Michael Cohen-Wolkowiez, MD, PhD (1)  ·  Peter J Barnes, FRS, FMedSci (1)  ·  Robert Dobbins, MD, PhD (1)  ·  William Man, MBBS, PhD (1)

Results publications

PMID 23507282, PMID 26089222

NIH funding

2014 (1)